Leviathan Therapeutics
Waltham, US · Founded 2022
Biotech
Founders & leadership
BG
Brian GastmanDirector
ML
Melissa LokugamageDirector
LM
Lauren MifflinExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$250KraisedJul 2022 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJul 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian GastmanDirector
- Melissa LokugamageDirector
- Lauren MifflinExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $250K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.